State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.
Nurs Open. 2023 Jun;10(6):3799-3809. doi: 10.1002/nop2.1638. Epub 2023 Mar 16.
To explore the relationship between the serum sodium level on admission and all-cause mortality in HF patients.
A single-center retrospective cohort study.
Patients hospitalized with HF at the Heart Failure Center, Fuwai Hospital, from November 2008 to November 2018 were enrolled.
A total of 3649 patients were included, and the mean sodium level was 137.19 ± 4.36 mmol/L, with a range from 115.6 to 160.9 mmol/L. During a median follow-up of 1101 days, mortality occurred in 1413 (38.7%) hospital survivors. After adjustment for age, sex, and other potential confounders, patients with sodium levels <135 mmol/L (hazard ratio [HR]: 1.67; 95% confidence interval [CI]: 1.29-2.16) and 135-137 mmol/L (HR: 1.34; 95% CI: 1.01-1.78) had an increased risk of all-cause mortality compared to those with sodium levels of 139-141 mmol/L.
探讨入院时血清钠水平与心力衰竭(HF)患者全因死亡率之间的关系。
单中心回顾性队列研究。
纳入 2008 年 11 月至 2018 年 11 月在阜外医院心力衰竭中心住院的 HF 患者。
共纳入 3649 例患者,平均血清钠水平为 137.19±4.36mmol/L,范围为 115.6 至 160.9mmol/L。中位随访 1101 天期间,1413 例(38.7%)住院幸存者死亡。在校正年龄、性别和其他潜在混杂因素后,血清钠水平<135mmol/L(风险比[HR]:1.67;95%置信区间[CI]:1.29-2.16)和 135-137mmol/L(HR:1.34;95% CI:1.01-1.78)的患者全因死亡率风险高于血清钠水平为 139-141mmol/L 的患者。